Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 9 of 9 for “"nonlinear mixed effects modelling"”.
-
Population pharmacokinetics: model-free approach and nonlinear mixed-effects modelling
… range of variability in the data. The non-linear mixed effect modelling is used to confirm the results of the model-free investigation. Model-free approach is successfully applied to several drugs. Non-linear Mixed Effects population models developed for the same data agree with its results. …
-
Application of nonlinear mixed effects modelling in the early phases of drug development
… dose range (10 to 40 mg). Analysis using nonlinear mixed effects modelling approach demonstrated that the selected doses only covered 20% (70% to 90%) of the upper part of the estimated dose response relationship. It was concluded that a lower dose strength would be required to allow …
-
Improving Precision of Vancomycin Dosing in Neonatal Sepsis based on Clinical Outcome Evaluation and Population Pharmacokinetics
… A popPK model was derived and validated using nonlinear mixed effects modelling. The predictive performance of the derived popPK model was compared against published popPK models. Monte Carlo simulations (MCS) were performed to derive optimal dosing regimens. Results: A one-compartment model …
-
A scoping review on the use of telerehabilitation in physiotherapy in low and middle income countries
… anti-TB drugs and antiretroviral therapy (ART). Modelling and simulation was performed using nonlinear mixed-effects modelling in the software NONMEM®. Results: A two-compartment disposition model with transit absorption best fitted the pharmacokinetic data. Allometry using fat-free mass and …
-
Pharmacometric analysis of monoclonal antibodies to support clinical decision-making
… Within this thesis the first population nonlinear mixed-effects (NLME) PK/PD model that quantitatively describes the IFX dose-exposure-CRP concentration relationship was developed. The model provides mechanistic insights, e.g. on significant factors influencing the IFX PK and the maximum …
-
Optimisation of congenital adrenal hyperplasia therapy in paediatric and foetal populations by leveraging pharmacometrics
… replacement due to its lower risk for adverse effects whereas adult patients receive more potent glucocorticoids, e.g., dexamethasone (Dex). Especially in paediatrics, dried blood spot (DBS) sampling represents a highly advantageous alternative to plasma sampling. The major advantages include …
-
Pharmacokinetic modelling of clinically relevant situations in the treatment of hemophilia A and B
Hemophilia is a congenital bleeding disorder caused by deficiency of clotting factor VIII (FVIII; hemophilia A) or IX (FIX; hemophilia B). Severe hemophilia patients have less than 1% (or 1 IU/dL) of normal factor activity, and often experience spontaneous bleeding episodes. This often occurs in …
-
Pharmacokinetics of Mycophenolic Acid in Patients post Hematopoietic Stem Cell Transplantation
… quantified using the validated UPLC-MS/MS assay. Nonlinear mixed-effects modelling (NONMEM) was employed to analyze MPA pharmacokinetic data. A total of 89 unbound MPA plasma concentration-time datum points from 23 patients with a median age of 3 years (range, 0.2-20 years) were available for …
-
The development of a mathematical modelling framework to translate TB vaccine responses between species and predict the most immunogenic dose in humans using animal data
… (IS/ID) mathematical modelling. My aims for this thesis were 1) to establish differences in Bacillus Calmette–Guérin (BCG) Interferon-Gamma (IFN-γ) response by human subpopulation, then develop a IS/ID model to represent these response dynamics and identify the most …